¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Brazelton's Neonatal Behavioural Assessment Scale"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • adaptive behavior scale
    ÀûÀÀÇൿôµµ
  • abnormal involuntary movement scale
    ºñÁ¤»óºÒ¼öÀǿôµµ
  • adhesive scale
    À¯Âø¼ººñ´Ã
  • beam scale
    ´ëÀú¿ï
  • clinical dementia rating scale
    ÀÓ»óÄ¡¸ÅÆò°¡Ã´µµ
  • cognitive scale
    Àνĵî±Þ
  • Conners hyperactivity rating scale
    Äڳʽº°ú´ÙȰµ¿Æò°¡Ã´µµ
  • Cattell infant intelligence scale
    Ä¿ÅÚ¿µ¾ÆÁö´Éôµµ
  • Celsius scale
    ¼·¾¾´«±Ý, ¼¿½Ã¿ì½º´«±Ý
  • defensive functioning scale
    ¹æ¾î±â´Éôµµ
  • depression self-rating scale
    ¿ì¿ïÁõÀÚ±âÆò°¡Ã´µµ
  • dichotomous scale
    À̺Ðôµµ, µÎ°¥·¡Ã´µµ
  • fish scale gallbladder
    ºñ´Ã¾µ°³, ºñ´Ã´ã³¶
  • Fahrenheit scale
    È­¾¾´«±Ý, ÆÄ·»ÇÏÀÌÆ®´«±Ý
  • Glasgow coma scale
    ±Û·¡½º°íÈ¥¼öôµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal death rate
    (¢¡neonatal mortality rate) ½Å»ý¾Æ»ç¸Á·ü
  • neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • abnormal involuntary movement scale
    ºñÁ¤»óºÒ¼öÀǿôµµ
  • adhesive scale
    À¯Âø¼ººñ´Ã
  • beam scale
    ´ëÀú¿ï
  • boiler scale
    °ü¼®
  • calibration scale
    ȯ»êÇ¥
  • Cattell infant intelligence scale
    Ä«ÅÚ¿µ¾ÆÁö´Éôµµ
  • Celsius scale
    ¼·¾¾´«±Ý
  • clinical dementia rating scale
    ÀÓ»óÄ¡¸ÅÆò°¡Ã´µµ
  • cognitive scale
    ÀνÄÀÚ
  • Conners hyperactivity rating scale
    Äڳʰú´ÙȰµ¿Æò°¡Ã´µµ
  • defensive functioning scale
    ¹æ¾î±â´Éôµµ
  • depression self-rating scale
    ¿ì¿ïÁõÀÚ±âÆò°¡Ã´µµ
  • dichotomous scale
    À̺Ðôµµ, µÎ°¥·¡Ã´µµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • logarithmic scale
    ·Î±×´«±Ý, ´ë¼ö´«±Ý, ·Î±×ÀÚ.
  • micaceous scale
    ¿î¸ð»óÀμ³
  • musical scale
    À½°è(ëåÍ­).
  • placoid scale
    ¼ø¸°(âäìç)
  • resource based relative value scale(RBRVS)
    Áö¿ø±âÁØ »ó´ë°¡Ä¡, ÀÇ·á¼ö°¡ Ã¥Á¤ÀÇ Åä´ë·Î Ȱ¿ëµÊ.
  • scala consistentiae ³ª =consistency scale
    (ÀڱðæºÎ)°æµµÃ´µµ (í­ÏàÌòÝ»Ìãöôô©Óø).
  • scale
    ºñ´Ã,Àμ³
  • scale
    Àμ³(ìèàÚ), ºñ´Ã
  • scale of turbulence
    ¿Í·ù(è¾êü)ÀÇ ´«±Ý.
  • sliding scale of fee
    ±¼½ÅÁ¦.
  • social adjustment scale-II(SAS-II)
    »çȸÀûÀÀôµµ-II
  • spring scale
    ź¼ºÀú¿ï.
  • synaptic scale
    ½Ã³³½ººñ´Ã.
  • tangent scale
    Á¢¼±Ã´(ïÈàÊô©).
  • tangent scale
    źÁ¨Æ®´«±Ý(ÀÚ), Á¢¼±´«±Ý(ÀÚ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ADAS Alzheimer disease assessment scale
ADAS-COG cognitive portion of the Alzheimer's Disease Assessment Scale
CGAS Children's Global Assessment Scale
GAF global assessment of functioning [scale]
GAIPAS General Audit Inpatient Psychiatric Assessment Scale
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SCAG Sandoz Clinical Assessment Geriatric Scale
SANS Scale for Assessment of Negative Symptoms
SANS Scale for the Assessment of Negative Symptoms
SAPS Scale for the Assessment of Positive Symptoms
BFNC Benign Familial Neonatal Convulsions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal maxillitis
    ½Å»ý¾Æ »ó¾Ç°ñ
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • neonatal tetany
    ½Å»ý¾Æ Åן´Ï
  • neonatal thyrombocytopenia
    ½Å»ý¾Æ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • no scale
    ºñ ´«±Ý
  • relative scale
    »ó´ë ôµµ
  • scale
    °è´Ü ±¸Á¶, ºñ´Ã, Àμ³, ôµµ, ´«±Ý, ÀÚ Àú¿ï, ¹þ°Ü³»´Ù
    üǥ¸é»óÀÇ °¢ÁúÈ­µÈ »óÇÇ ¼¼Æ÷, ¶Ç´Â ÇǺο¡¼­ÀÇ ³«¼³°ú °°Àº ¾ã°í ¹ÐÁýµÈ ÆòÆÇ»ó ±¸Á¶. ¾î¶² ¼ºÁúÀ» Æò°¡ ¶Ç´Â ÃøÁ¤ÇÒ ¼ö ÀÖ´Â µµÇ¥ ¶Ç´Â ÀåÄ¡·Î¼­, Áï ¹Ì¸® °áÁ¤µÈ ´ÜÀ§¸¦ ³ªÅ¸³»´Â ±ÔÄ¢ÀûÀÎ °£°ÝÀ¸·Î Á÷¼± »ó¿¡ Ç¥½ÃÇÑ °Í µî. Ä¡¾ÆÀÇ Ç¥¸é¿¡¼­ ºÎÂø¹°À» Á¦°ÅÇÏ´Â °Í°ú °°ÀÌ Ã¼Ç¥¸é¿¡¼­ ¹°ÁúÀ» Á¦°ÅÇÏ´Â °Í. °ÇÁ¶Çϰųª ½ÀÇÑ °¢ÁúÀÇ µ¢¾î¸®·Î, °¢Áú »ý¼ºÀÌ »¡¶óÁö°Å³ª Á¤»ó °¢ÁúÈ­ °úÁ¤ÀÇ ÀÌ»óÀ¸·Î ¹ÚÅ»µÇ¾î ¹ß»ýÇÑ´Ù.
  • social readjustment rating scale
    »çȸ ÀçÀûÀÀ Æò°¡ ôµµ
  • TMJ Scale
    ÃøµÎÇϾǰüÀý Áö¼ö
  • tone scale
    À½°è
  • uniform scale
    ±Õµî ´«±Ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
technology assessment, biomedical Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
(12 Dec 1998)
environmental assessment (EA) A public document that analyzes a proposed federal action for the possibility of significant environmental impacts. The analysis is required by NEPA. If the environmental impacts will be significant, the federal agency must then prepare an environmental impact statement.
(05 Dec 1998)
united states office of technology assessment An office established to help congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications.
(12 Dec 1998)
anaemia, neonatal The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation.
(12 Dec 1998)
benign neonatal convulsions A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á